As of 2025-04-24, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (80.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -3128.0%.
The range of the Relative Valuation is (66.29) - (104.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 43.8x | 36.6x |
| Forward P/E multiples | 23.8x - 44.7x | 30.6x |
| Fair Price | (66.29) - (104.70) | (80.24) |
| Upside | -2601.7% - -4050.8% | -3128.0% |
| Date | P/E |